3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Myasthenia Gravis
1
Adrenal Insufficiency
1
Interventions
Letrozole
6
Cisplatin
5
Tamoxifen
4
Nivolumab
4
Carboplatin
4
Anastrozole
4
ribociclib
3
exemestane
3
atezolizumab
3
Vancomycin
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Human Papillomavirus Recombinant Vaccine nonavalent
3
Dexamethasone
3
Bevacizumab
3
trametinib
2
toripalimab
2
relatlimab
2
pembrolizumab
2
encorafenib
2
dabrafenib
2
binimetinib
2
asciminib
2
Vincristine
2
Sodium Chloride
2
Rituximab
2
Prednisone
2
Papillomavirus Vaccines
2
Methotrexate
2
Medroxyprogesterone Acetate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
ravulizumab
×
90 days
×
Clear all
NCT07221838
2026-04-09
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4
Recruiting
75 enrolled